Most Recent
A shareholder class action against engineering services firm Worley has prevailed after a hard-fought battle over damages, in a major decision following two trips to the Full Federal Court.
The Commonwealth Bank has urged the High Court to uphold a ruling rejecting shareholders' damages claims in two class actions, saying the decision correctly rejected their "conflation of materiality with loss".
The ASX is fighting for a key witness in ASIC’s case over alleged misleading statements concerning its CHESS replacement program to appear at an upcoming trial, saying he needs to be cross-examined in person.
Construction PRO
Magic Circle firm Clifford Chance, which boasts one of the leading projects and energy transition teams in the UK, is deepening its expertise in Australia, hiring a lawyer from HSF Kramer to build an environment and planning team.
The Full Court has found women-only social media app Giggle for Girls committed direct discrimination on the basis of gender identity by excluding a transgender woman from the platform and slapped its founder with aggravated damages for repeated misgendering during trial.
A labour hire firm operated by BHP units has won a fight with a union over public holiday allowances and shift lengths for black coal mine workers, with an appeals court finding it's not necessary for workers to have the same holidays off.
A barrister for KIIS FM shock jock Kyle Sandilands has responded to allegations that he bullied co-host Jackie 'O' Henderson by claiming his behaviour was desirable under his contract, saying “if you buy Kyle, you get Kyle”.
Environmental group Greenpeace won't take its case alleging Woodside misled the public by greenwashing its oil and gas projects to trial, after a judge tossed a similar case against Santos in February.
A judge has rejected a bid to amend a shareholder class action against Beach Energy, saying the way the applicant had articulated its case on loss by reference to an expert report was “apt to lead to confusion”.
Melbourne-based biopharma Telix has filed a lawsuit against Purdue Research Foundation seeking to invalidate its patent for blockbuster prostate cancer treatment Pluvicto.